» Articles » PMID: 29180911

Burning Mouth Syndrome: Aetiopathogenesis and Principles of Management

Overview
Journal Pain Res Manag
Date 2017 Nov 29
PMID 29180911
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Burning mouth syndrome (BMS) is a chronic debilitating oral condition characterised by a burning sensation of the oral mucosa in an otherwise apparently normal person. Its aetiology and pathogenesis are obscure, but both psychogenic factors and peripheral and central neuropathies appear to be implicated. There is no cure for BMS, and treatment with either local or systemic medications focuses on the relief of symptoms and on improving quality of life. In recalcitrant cases, psychological/psychiatric intervention may be helpful. In order to improve treatment outcomes, a better understanding of the pathogenesis of this syndrome might provide a basis for the development of more effective management strategies. In this short review, we discuss current knowledge of the diagnosis, aetiopathogenesis, and management of BMS.

Citing Articles

Comparison of Salivary Opiorphin in Burning Mouth Syndrome and Healthy Subjects and Its Correlation With Psychiatric Disorders.

Dalirsani Z, Amirchaghmaghi M, Semnani M, Talebi M, Hashemy S, Shakeri M Clin Exp Dent Res. 2024; 10(6):e934.

PMID: 39616519 PMC: 11608505. DOI: 10.1002/cre2.934.


The Trigeminal Sensory System and Orofacial Pain.

Kim H, Chung K, Xing J, Kim H, Youn D Int J Mol Sci. 2024; 25(20).

PMID: 39457088 PMC: 11508441. DOI: 10.3390/ijms252011306.


Potential salivary and serum biomarkers for burning mouth syndrome and their relationship with anxiety/depression.

Zhang Y, Ye S, Zhang Y, Sun H, Zhao X, Shen X J Dent Sci. 2024; 19(2):1052-1060.

PMID: 38618099 PMC: 11010615. DOI: 10.1016/j.jds.2023.06.003.


Is Burning Mouth Syndrome Associated with Extraoral Dryness? A Systematic Review.

Le K, DosSantos M, Gazerani P J Clin Med. 2023; 12(20).

PMID: 37892662 PMC: 10607144. DOI: 10.3390/jcm12206525.


Valproate-induced burning mouth syndrome in a male with fibromyalgia and bipolar spectrum disorder.

Raia A, Caruso V, Montalbano C, Migli L, Raia C, Pini S Arch Clin Cases. 2023; 10(3):125-127.

PMID: 37736595 PMC: 10510332. DOI: 10.22551/2023.40.1003.10257.


References
1.
Laklouk M, Baranidharan G . Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability. Patient Prefer Adherence. 2016; 10:1913-1918. PMC: 5038568. DOI: 10.2147/PPA.S76506. View

2.
Jaaskelainen S . Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol. 2011; 123(1):71-7. DOI: 10.1016/j.clinph.2011.07.054. View

3.
de Moraes M, Bezerra B, da Rocha Neto P, de Oliveira Soares A, Pereira Pinto L, Costa A . Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature. J Oral Pathol Med. 2011; 41(4):281-7. DOI: 10.1111/j.1600-0714.2011.01100.x. View

4.
Cui Y, Xu H, Chen F, Liu J, Jiang L, Zhou Y . Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis. Oral Dis. 2015; 22(6):503-11. DOI: 10.1111/odi.12422. View

5.
Speciali J, Stuginski-Barbosa J . Burning mouth syndrome. Curr Pain Headache Rep. 2008; 12(4):279-84. DOI: 10.1007/s11916-008-0047-9. View